摘要
目的探讨应用低分子肝素钙治疗进展型脑梗死患者的临床治疗效果。方法回顾性分析该院治疗的63例进展型脑梗死患者的病例资料,所有患者随机分为3组,对照1组患者给予常规治疗,对照2组在对照1组基础上给予纤溶酶药物治疗,治疗组在对照1组基础上应用低分子肝素钙进行治疗,并对3组患者治疗效果进行比较。结果治疗组治疗效果明显高于对照1组、2组,比较差异有统计学意义(P<0.05)。结论低分子肝素钙药效持续时间长,治疗效果明显。
Objective To investigate the clinical effect of low molecular weight heparin calcium on patients with progressive cerebral infarction. Methods The clinical data of 63 patients with progressive cerebral infarction treated in our hospital were analyzed retrospectively. All the patients were randomly divided into 3 groups, control group 1, control group 2 and treatment group. The control group 1 was treated with conventional therapy, the control group 2 was treated with fibrinolytic enzyme drug therapy on the basis of conventional therapy, and the treatment group was treated with low molecular weight heparin calcium on the basis of conventional therapy. The treatment effects of the 3 groups were compared. Results The therapeutic effect of the treatment group was significantly higher than that of th~ control group 1 and control group 2, the differences were statistically significant （P〈0.05）. Conclusion Low molecular weight heparin calcium has a long duration of effect and the treatment effect is obvious.
出处
《中外医疗》
2013年第29期3-4,共2页
China & Foreign Medical Treatment
关键词
进展型脑梗死
低分子肝素钙
纤溶酶
Progressive cerebral infarction
Low molecular weight heparin calcium
Plasmin
